日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

A broad-spectrum SARS-CoV-2 RBD vaccine with selected high-impact mutations and novel adjuvant induces durable T cell response and broad protection in mice.

一种含有特定高影响突变和新型佐剂的广谱 SARS-CoV-2 RBD 疫苗，可在小鼠体内诱导持久的 T 细胞反应和广泛的保护作用。

期刊:Frontiers in Cellular and Infection Microbiology
影响因子:4.8
doi:10.3389/fcimb.2025.1690554
Chen Xianying, Zhang Yuzhen, Yang Shimin, Chen Yan, Qian Shengnan, Zhang Zhen, Liu Qianyun, Ma Chengbao, Yu Weiyi, Feng Jiangpeng, Liu Jiejie, Guo Ming, Huang Zhixiang, Wang Xin, Chen Jie, Zhao Haiyan, Yan Huan, Lan Ke, Chen Yu, Zhou Li
SARS-CoV-2
细胞生物学
T细胞
发表日期：2025
文献求助 收藏

ACE2-using merbecoviruses: Further evidence of convergent evolution of ACE2 recognition by NeoCoV and other MERS-CoV related viruses

利用ACE2的默贝病毒：新冠状病毒和其他MERS-CoV相关病毒对ACE2识别的趋同进化的进一步证据

期刊:Cell Insight
影响因子:
doi:10.1016/j.cellin.2023.100145
Xiong, Qing; Ma, Chengbao; Liu, Chen; Tong, Fei; Huang, Meiling; Yan, Huan
微生物学
新冠
ACE2
发表日期：2024
文献求助 收藏

Drastic decline in sera neutralization against SARS-CoV-2 Omicron variant in Wuhan COVID-19 convalescents

武汉新冠肺炎康复者血清中和SARS-CoV-2 Omicron变异株的活性急剧下降

期刊:Emerging Microbes & Infections
影响因子:7.5
doi:10.1080/22221751.2022.2031311
Ma, Chengbao; Chen, Xianying; Mei, Fanghua; Xiong, Qing; Liu, Qianyun; Dong, Lianghui; Liu, Chen; Zou, Wenjing; Zhan, Faxian; Hu, Bing; Liu, Yingle; Liu, Fang; Zhou, Li; Xu, Junqiang; Jiang, Yongzhong; Xu, Ke; Cai, Kun; Chen, Yu; Yan, Huan; Lan, Ke
肺炎
新冠
SARS-CoV-2
微生物学
发表日期：2022
文献求助 收藏

Antibody neutralization to SARS-CoV-2 and variants after 1 year in Wuhan, China.

在中国武汉一年后，针对 SARS-CoV-2 及其变种的抗体中和情况

期刊:Innovation (Camb)
影响因子:
doi:10.1016/j.xinn.2021.100181
Liu Qianyun, Xiong Qing, Mei Fanghua, Ma Chengbao, Zhang Zhen, Hu Bing, Xu Junqiang, Jiang Yongzhong, Zhan Faxian, Zhou Suhua, Tao Li, Chen Xianying, Guo Ming, Wang Xin, Fang Yaohui, Shen Shu, Liu Yingle, Liu Fang, Zhou Li, Xu Ke, Ke Changwen, Deng Fei, Cai Kun, Yan Huan, Chen Yu, Lan Ke
炎症/感染
新冠
发表日期：2022
文献求助 收藏